Jeffrey Swigris is a Respiratory physician affiliated with National Jewish Health. OpenAlex indexes 287 publications with 32,858 citations (h-index 48); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-388-4461Provider last certified this registry record 11 Nov 2020.
Clinical trials
- Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Sponsor: National Jewish Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202510 payments
- United Therapeutics CorporationProgram year202512 payments
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
39.1%Kinase inhibitor26.8%Ofev100%Part D≥24 patientsPyridone9.1%Pirfenidone100%Part D<11 patients+ 1 more class in this area
Respiratory
24.7%Corticosteroid12.3%Symbicort32%Budesonide-Formoterol Fumarate28%Breztri Aerosphere21%Trelegy Ellipta20%Part D<11 patientsbeta2-Adrenergic Agonist9.9%Albuterol Sulfate Hfa84%Ventolin Hfa16%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
17.3%Corticosteroid13.6%Prednisone100%Part D≥49 patientsPotassium supplement2.3%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- 1/2 Efficacy and Safety of Obinutuzumab in Connective Tissue Disease-Related Interstitial Lung Disease
National Jewish Health
FY2026$1,000,770UG3HL183035 - Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
National Jewish Health
FY2013$122,493K23HL092227 - Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
National Jewish Health
FY2012$130,053K23HL092227
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes
American Journal of Respiratory and Critical Care Medicine
2024 - Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants
American Journal of Respiratory and Critical Care Medicine
2023 - Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Crapo, MD
National Jewish Health
Barry Make, MD
National Jewish Health
Michael Wechsler, MD
National Jewish Health
Pamela Zeitlin, MD
National Jewish Health
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”